Bendectin and Birth Defects

The Challenges of Mass Toxic Substances Litigation

Michael D. Green

$75.95 $64.26

Paperback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

University of Pennsylvania Press
01 January 1998

Legal ethics & professional conduct; Regulation of legal profession; Criminal law & procedure; Medicolegal issues; Congenital diseases & disorders; Gynaecology & obstetrics

Benedictin was prescribed to more than thirty-five million American women from its introduction in 1956 until 1983, when it was withdrawn from the market. The drug's manufacturer, Merrill Dow Pharmaceuticals, a major U.S. pharmaceutical firm, joined a list of other companies whose product liabilities would result in precedent-setting litigation. Before it was over, the Benedictin litigation would involve 2,000 claimants over a fifteen-year period. Michael D. Green offers a comprehensive overview of the Benedictin case and highlights many of the key issues in mass toxic substances litigation, comparing individual and collective forms of litigation, and illustrating the misunderstandings between scientists and lawyers about the role of science in providing evidence for the legal system.

By: Michael D. Green
Imprint: University of Pennsylvania Press
Country of Publication: United States
Edition: New edition
Dimensions: Height: 229mm, Width: 152mm, Spine: 20mm
Weight: 600g
ISBN: 9780812216455
ISBN 10: 0812216458
Pages: 384
Publication Date: 01 January 1998
Audience: College/higher education , Professional and scholarly , Professional & Vocational , A / AS level , Further / Higher Education
Format: Paperback
Publisher's Status: Active

Preface Acknowledgments Chapter 1-A Birth Defect Child Is Born Chapter 2-Locating Bendectin within the Mass Toxic Landscape Chapter 3-The Science of Determining Toxic Causation Chapter 4-The Food and Drug Administration Chapter 5-The Wm. S. Merrell Company Chapter 6-A Mother's Quest Chapter 7-The Mekdeci Case Chapter 8-The Unraveling of Mekdeci Chapter 9-The Proliferation of Bendectin Litigation Chapter 10-Litigating a Multidistrict Case Chapter 11-The Withdrawal of Bendectin Chapter 12-Forging a Mass Toxic Substances Trial Chapter 13-The Settlement and Unsettlement of MDL-486 Chapter 14-The MDL-486 Trial Chapter 15-Aggregative Procedure in Mass Toxic Substances Litigation Chapter 16-The Third Phase of Bendectin Litigation: Oxendine, Richardson, and the Individual Trials Chapter 17-The Legacy of Bendectin for Toxic Causation Law Chapter 18-The Lessons and Non-Lessons of Bendectin Litigation Selected Bibliography Index

Michael D. Green is Professor of Law at the University of Iowa.

Reviews for Bendectin and Birth Defects: The Challenges of Mass Toxic Substances Litigation

Should be required reading in all law schools, and should be part of continuing education activities for judges and attorneys. -Judicature Important reading for obstetrician-gynecologists and family physicians who provide obstetrical services. -New England Journal of Medicine